HuwilerVVMaissen-AbgottsponSStangaZMhlebachSTreppRBallyLet al
No human clinical trials have been published as of 2026
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in San Saba, Texas who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year
Viking Therapeutics: Financial & Strategic Conclusion Viking ended 2025 with $706 million in cash, cash equivalents and short-term investments
In summary: Saffron helps balance serotonin and dopamine pathways, reducing emotional reactivity and promoting calmer, more focused attention over time
500K people track their GLP-1 with MeAgain, and the app has a 4.8-star App Store rating across 25K ratings and is available on iPhone and Android